Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hampel

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Actas Urologicas Espanolas|May 24, 2011
[EAU Guidelines on Urinary Incontinence]J W Thüroff, P Abrams, K-E Andersson, et al.
Allergy and Asthma Proceedings|October 3, 2012
Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitisJulius H van Bavel, Paul H Ratner, Niran J Amar, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2006
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptomsBruce G Martin, Charles P Andrews, Julius H van Bavel, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1995
Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medicationsJ Grossman, C Banov, P Boggs, et al.
Clinical Therapeutics|October 9, 2007
Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trialCraig LaForce, Choy Y Man, Frederick W Henderson, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2017
Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studiesPaul Ratner, Charles P Andrews, Frank C Hampel, et al.
The Journal of Family Practice|September 2, 1998
A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitisP H Ratner, J H van Bavel, B G Martin, et al.
Schmerz (Berlin, Germany)|September 7, 2006
[Pain therapy in addicted patients]C Hampel, M Schenk, H Göbel, et al.
Allergy and Asthma Proceedings|August 18, 2006
Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placeboFrank C Hampel, Paul H Ratner, Niran J Amar, et al.
American Journal of Rhinology & Allergy|October 13, 2017
Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto RicoW W Carr, D I Bernstein, F C Hampel, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Actas Urologicas Espanolas|May 24, 2011
[EAU Guidelines on Urinary Incontinence]J W Thüroff, P Abrams, K-E Andersson, et al.
Allergy and Asthma Proceedings|October 3, 2012
Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitisJulius H van Bavel, Paul H Ratner, Niran J Amar, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2006
Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptomsBruce G Martin, Charles P Andrews, Julius H van Bavel, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1995
Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medicationsJ Grossman, C Banov, P Boggs, et al.
Clinical Therapeutics|October 9, 2007
Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trialCraig LaForce, Choy Y Man, Frederick W Henderson, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2017
Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studiesPaul Ratner, Charles P Andrews, Frank C Hampel, et al.
The Journal of Family Practice|September 2, 1998
A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitisP H Ratner, J H van Bavel, B G Martin, et al.
Schmerz (Berlin, Germany)|September 7, 2006
[Pain therapy in addicted patients]C Hampel, M Schenk, H Göbel, et al.
Allergy and Asthma Proceedings|August 18, 2006
Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placeboFrank C Hampel, Paul H Ratner, Niran J Amar, et al.
American Journal of Rhinology & Allergy|October 13, 2017
Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto RicoW W Carr, D I Bernstein, F C Hampel, et al.
Pageof 10